WESTON, Fla., Nov. 21, 2023 /PRNewswire/ - Apotex Corp. announced today the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United ...
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically ...
Please provide your email address to receive an email when new articles are posted on . Teriparatide restores bone mineral quality to premenopausal levels for women with postmenopausal osteoporosis if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback